Ritu Aneja
Impact in
- Cell Biology top 0.5%
- Microtubule and mitosis dynamics
- Cancer Research top 2%
- Cancer Genomics and Diagnostics
Papers in
-
- Cancer Genomics and Diagnostics 25
- Breast Cancer Treatment Studies 22
- Cell Biology 57
- Microtubule and mitosis dynamics 52
- Co-authors
- Padmashree C.G. RidaJun ZhouAngela OgdenRamesh ChandraHarish C. JoshiSushma R. GundalaRichard A. StantonJames H. Nettles
- Journals
- Cancers (7 papers)Cancer Research (7 papers)Journal of Clinical Oncology (7 papers)Medicinal Research Reviews (7 papers)Journal of Biological Chemistry (6 papers)
- Partner nations
- United StatesIndiaChina
In The Last Decade
Ritu Aneja
214 papers receiving 6.3k citations
Peers
Comparison fields: 5 of 157
- Cell Biology 1.2k
- Cancer Research 1.0k
- Oncology 1.7k
- Pharmacology 507
- Toxicology 169
Countries citing papers authored by Ritu Aneja
This map shows the geographic impact of Ritu Aneja's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ritu Aneja with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ritu Aneja more than expected).
Fields of papers citing papers by Ritu Aneja
This network shows the impact of papers produced by Ritu Aneja. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ritu Aneja. The network helps show where Ritu Aneja may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ritu Aneja, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 4 | |
| 4 | 2023 | 5 | |
| 5 | 2023 | 2 | |
| 6 | 2023 | 5 | |
| 7 | 2022 | 20 | |
| 8 | 2022 | 5 | |
| 9 | 2021 | 13 | |
| 10 | 2021 | 15 | |
| 11 | 2020 | 3 | |
| 12 | 2019 | 37 | |
| 13 | 2019 | 30 | |
| 14 | 2018 | 8 | |
| 15 | 2018 | 59 | |
| 16 | 2017 | 14 | |
| 17 | 2012 | 33 | |
| 18 | Potent Anti-Inflammatory Activity of Novel Microtubule-Modulating Brominated Noscapine Analogs | 2010 | 1 |
| 19 | EM044, a novel noscapinoid induces apoptosis in prostate cancer cells while sparing the normal stroma | 2007 | 1 |
| 20 | Pongamia glabraの種子の新成分,6-メキシフロフラボン | 1963 | 1 |
About Ritu Aneja
Ritu Aneja is a scholar working on Cancer Research, Cell Biology, Oncology, Pharmacology and Molecular Biology, having authored 220 papers that have together received 6.4k indexed citations. Recurring topics across this work include Microtubule and mitosis dynamics (52 papers), Cancer Genomics and Diagnostics (25 papers), Breast Cancer Treatment Studies (22 papers), Cancer-related Molecular Pathways (21 papers), Cancer therapeutics and mechanisms (17 papers), Cancer Treatment and Pharmacology (13 papers), DNA Repair Mechanisms (10 papers) and Ginger and Zingiberaceae research (9 papers). The work is most often cited by research in Cell Biology (1.2k citations), Cancer Research (1.0k citations), Oncology (1.7k citations), Pharmacology (507 citations) and Toxicology (169 citations). Ritu Aneja has collaborated with scholars based in United States, India and China. Frequent co-authors include Padmashree C.G. Rida, Jun Zhou, Angela Ogden, Ramesh Chandra, Harish C. Joshi, Sushma R. Gundala, Richard A. Stanton, James H. Nettles, Kim M. Gernert and Michelle D. Reid. Their work appears in journals such as Cancers, Cancer Research, Journal of Clinical Oncology, Medicinal Research Reviews and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.